Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Gross Profit Growth (1y) (2013 - 2026)

Analysis

Iqvia Holdings (IQV) Gross Profit Growth (1y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 8.47%
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 12.01%
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -17.83%
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 1.08%
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 4.27%
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -45.38%
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 28.30%
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 44.95%
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.47%
Mar 31, 2026 4.39%
Dec 31, 2025 4.21%
Sep 30, 2025 -0.36%
Jun 30, 2025 -0.23%
Mar 31, 2025 0.39%
Dec 31, 2024 -0.86%
Sep 30, 2024 5.19%
Jun 30, 2024 3.19%
Mar 31, 2024 3.11%
Dec 31, 2023 4.35%
Sep 30, 2023 5.56%
Jun 30, 2023 6.20%
Mar 31, 2023 0.72%
Dec 31, 2022 4.72%
Sep 30, 2022 9.05%
Jun 30, 2022 8.52%
Mar 31, 2022 11.56%
Dec 31, 2021 12.97%
Sep 30, 2021 15.42%